Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCapricorn Energy PLC Regulatory News (CNE)

Share Price Information for Capricorn Energy PLC (CNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 166.00
Bid: 166.50
Ask: 170.50
Change: -5.94 (-3.45%)
Spread: 4.00 (2.402%)
Open: 171.00
High: 171.00
Low: 166.00
Prev. Close: 171.94
CNE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8. (EPT/RI) - Capricorn Energy plc

17 Oct 2022 07:40

RNS Number : 073D Morgan Stanley Co. Int'l plc 17 October 2022 160

FORM 8. (EPT/RI)

160

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8. of the Takeover Coe (the "Coe")

160

1.160160160160160160160160 KEY INFORMATION

160

(a) Name of exempt principal traer:

Morgan Stanley Co. International plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

160160160160 Use a separate form for each offeror/offeree

Capricorn Energy plc

(c) Name of the party to the offer with which exempt principal traer is connecte:

Capricorn Energy plc

() Date ealing unertaken:

14 October 2022

(e) In aition to the company in 1(b) above, is the exempt principal traer making isclosures in respect of any other party to this offer?

160160160160 If it is a cash offer or possible cash offer, state "N/A"

YES - Tullow Oil plc

160

2.160160160160160160160160 DEALINGS BY THE EXEMPT PRINCIPAL TRADER

160

Where there have been ealings in more than one class of relevant securities of the offeror or offeree name in 1(b), copy table 2(a), (b), (c) or () (as appropriate) for each aitional class of relevant security ealt in.

160

The currency of all prices an other monetary amounts shoul be state.

160

(a)160160160160160160160 Purchases an sales

160

Class of relevant security

Purchases/ sales

160

Total number of securities

Highest price per unit pai/receive

Lowest price per unit pai/receive

21/13p orinary

SALES

130,838

2.471 GBP

2.4240 GBP

21/13p orinary

PURCHASES

16,288

2.4740 GBP

2.4297 GBP

160

(b)160160160160160160160 Cash-settle erivative transactions

160

Class of relevant security

Prouct escription

e.g. CFD

Nature of ealing

e.g. opening/closing a long/short position, increasing/reucing a long/short position

Number of reference securities

Price per unit

21/13p orinary

CFD

increasing a long position

9,22

2.4323 GBP

21/13p orinary

CFD

increasing a long position

27,200

2.4348 GBP

21/13p orinary

CFD

increasing a long position

10,99

2.4370 GBP

21/13p orinary

CFD

increasing a long position

2,014

2.4382 GBP

21/13p orinary

CFD

increasing a long position

72

2.4418 GBP

21/13p orinary

CFD

increasing a long position

611

2.40 GBP

21/13p orinary

CFD

increasing a short position

100,000

2.4300 GBP

21/13p orinary

CFD

increasing a short position

16,96

2.4370 GBP

21/13p orinary

CFD

increasing a short position

1,040

2.4389 GBP

21/13p orinary

CFD

reucing a long position

9,22

2.434 GBP

21/13p orinary

CFD

reucing a long position

611

2.4636 GBP

21/13p orinary

CFD

reucing a short position

737

2.4280 GBP

21/13p orinary

CFD

reucing a short position

1,040

2.4340 GBP

21/13p orinary

CFD

reucing a short position

778

2.4340 GBP

21/13p orinary

CFD

reucing a short position

694

2.431 GBP

21/13p orinary

CFD

reucing a short position

6,136

2.4417 GBP

160

(c)160160160160160160160 Stock-settle erivative transactions (incluing options)

160

(i)160160160160160160160160 Writing, selling, purchasing or varying

160

Class of relevant security

Prouct escription e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry ate

Option money pai/ receive per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

160

(ii)160160160160160160160 Exercise

160

Class of relevant security

Prouct escription

e.g. call option

Exercising/ exercise against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

160

()160160160160160160160 Other ealings (incluing subscribing for new securities)

160

Class of relevant security

Nature of ealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

160

3.160160160160160160160160 OTHER INFORMATION

160

(a)160160160160160160160 Inemnity an other ealing arrangements

160

Details of any inemnity or option arrangement, or any agreement or unerstaning, formal or informal, relating to relevant securities which may be an inucement to eal or refrain from ealing entere into by the exempt principal traer making the isclosure an any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments an letters of intent shoul not be inclue.160 If there are no such agreements, arrangements or unerstanings, state "none"

NONE

160

160

(b)160160160160160160160 Agreements, arrangements or unerstanings relating to options or erivatives

160

Details of any agreement, arrangement or unerstaning, formal or informal, between the exempt principal traer making the isclosure an any other person relating to:

(i)160 the voting rights of any relevant securities uner any option or

(ii) the voting rights or future acquisition or isposal of any relevant securities to which any erivative is reference:

If there are no such agreements, arrangements or unerstanings, state "none"

NONE

160

160

160

Date of isclosure:

17 October 2022

Contact name:

Craig Horsley

Telephone number:

+44 141 24-7736

160

Public isclosures uner Rule 8 of the Coe must be mae to a Regulatory Information Service.160

160

The Panel's Market Surveillance Unit is available for consultation in relation to the Coe's ealing isclosure requirements on +44 (0)20 7638 0129.

160

The Coe can be viewe on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provie by RNS, the news service of the Lonon Stock Exchange. RNS is approve by the Financial Conuct Authority to act as a Primary Information Provier in the Unite Kingom. Terms an conitions relating to the use an istribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP aress to confirm compliance with the terms an conitions, to analyse how you engage with the information containe in this communication, an to share such analysis on an anonymise basis with others as part of our commercial services. For further information about how RNS an the Lonon Stock Exchange use the personal ata you provie us, please see our Privacy Policy.160 END160160FERMRBFTMTJBMPT
Date   Source Headline
11th May 20237:19 amRNSTransaction in Own Shares
10th May 20237:12 amRNSTransaction in Own Shares
9th May 20237:07 amRNSTransaction in Own Shares
5th May 20237:11 amRNSTransaction in Own Shares
4th May 20232:50 pmRNSTransaction in Own Shares
2nd May 20237:00 amRNSHolding(s) in Company
28th Apr 202312:09 pmRNSCirc re. Return of US$450 million to shareholders
28th Apr 20239:44 amRNSTotal Voting Rights
27th Apr 20237:00 amRNSFull Year Results Announcement
17th Apr 20239:28 amRNSHolding(s) in Company
13th Apr 202310:04 amRNSHolding(s) in Company
11th Apr 20234:40 pmRNSDirector/PDMR Shareholding
11th Apr 202311:59 amRNSDirectorate Change
31st Mar 20233:06 pmRNSTotal Voting Rights
23rd Mar 20233:30 pmRNSCost base update
23rd Mar 20237:00 amRNSChange of Adviser
17th Mar 20239:20 amRNSDrilling/Production Report
28th Feb 20231:35 pmRNSTotal Voting Rights
27th Feb 20237:00 amRNSOperational, Trading and Business Update
22nd Feb 20234:09 pmRNSGM Statement
17th Feb 20232:00 pmRNSHolding(s) in Company
15th Feb 202310:31 amRNSUpdate on NewMed transaction and Strategic Review
14th Feb 20234:54 pmRNSDirector Declaration
1st Feb 20236:06 pmRNSNew Board to undertake Strategic Review
1st Feb 20233:20 pmRNSResult of Meeting
1st Feb 202311:56 amRNSResult of Meeting
31st Jan 20236:02 pmRNSPublication of Supplementary Prospectus & Circular
31st Jan 20232:19 pmRNSTotal Voting Rights
24th Jan 20237:10 amRNSHolding(s) in Company
24th Jan 20237:00 amRNSBoard Changes
20th Jan 20232:25 pmRNSHolding(s) in Company
19th Jan 20238:11 amRNSHolding(s) in Company
17th Jan 20232:11 pmRNSLetter to shareholder Palliser
17th Jan 20238:16 amRNSHolding(s) in Company
16th Jan 202311:24 amRNSInvestor Update Presentation
13th Jan 20232:11 pmRNSPublication of a Prospectus
9th Jan 20237:02 amRNSPalliser Letter
9th Jan 20237:00 amRNSNotice of GM
5th Jan 202312:03 pmRNSHolding(s) in Company
5th Jan 20237:00 amRNSUpdate to Shareholders
4th Jan 202310:55 amRNSHolding(s) in Company
30th Dec 202211:13 amRNSTotal Voting Rights
29th Dec 20222:51 pmRNSHolding(s) in Company
28th Dec 20221:09 pmRNSHolding(s) in Company
28th Dec 20229:28 amRNSHolding(s) in Company
28th Dec 20229:22 amRNSHolding(s) in Company
22nd Dec 20224:02 pmRNSHolding(s) in Company
22nd Dec 20223:44 pmRNSHolding(s) in Company
22nd Dec 20228:11 amRNSHolding(s) in Company
22nd Dec 20228:04 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.